Hyphanox itraconazole: Completed Phase III enrollment

BTRX completed enrollment of >1,370 patients in a double-blind, placebo-controlled, international Phase III trial to evaluate non-inferiority of 200 mg Hyphanox capsule given once daily vs. 2 100 mg c...